PD-Rx Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Aug 20, 2026
  • No warning letters matched by name
Inspections 4 0 OAI
Recalls 25 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

PD-Rx Pharmaceuticals, Inc. has 25 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "PD-Rx Pharmaceuticals, Inc." is on file.

What these totals cover: FDA records filed under the name "PD-Rx Pharmaceuticals, Inc." and its spelling variant "Pd-Rx Pharmaceuticals".

Latest recall
D-0163-2025 · Class II · Dec 4, 2024
Latest inspection
Aug 20, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls25Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections4Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

PD-Rx Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

PD-Rx Pharmaceuticals, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 5 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202500000
202400010
202300050
202210030
202100000
202000070
201900010
201800020
201700020

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing PD-Rx Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check PD-Rx Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

25 recall records from Apr 29, 2015 to Dec 4, 2024. Showing the 20 most recent. View all 25 recall records

NumberClassProductDate
D-0163-2025Class IIDULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma…Dec 4, 2024
D-0561-2023Class IISimvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx…Apr 6, 2023
D-0560-2023Class IISimvastatin USP 20 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx…Apr 6, 2023
D-0558-2023Class IISimvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx…Apr 6, 2023
D-0557-2023Class IIMontelukast Sodium USP, 10 mg, 30 count-bottles, Rx only, Intas Pharm, Limited Ahmedabad 380 054…Apr 6, 2023
D-0559-2023Class IIGlimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals…Apr 6, 2023
D-1162-2022Class IILosartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx…Jun 6, 2022
D-1161-2022Class IILosartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx…Jun 6, 2022
D-1163-2022Class IILosartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed and Packaged By: PD-Rx…Jun 6, 2022
D-0060-2021Class IImetformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127…Oct 6, 2020
D-0059-2021Class IImetformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 72789-009-60; c) 90…Oct 6, 2020
D-0005-2021Class IINature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg…Sep 17, 2020
D-1333-2020Class IImetFORMIN HCL ER 500 mg, a) 30 tablets (NDC 72789-009-30); b) 60 tablets (NDC 72789-009-60); c) 90…Jun 5, 2020
D-1307-2020Class IImetFORMIN HCL ER USP 500 mg, a) 30 tablets (NDC: 43063-428-30); b) 60 tablets (NDC: 43063-428-60)…Jun 5, 2020
D-1276-2020Class IIDoxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b)…May 15, 2020
D-0826-2020Class IIranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count…Jan 10, 2020
D-0341-2021Class IILosartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK…Mar 8, 2019
D-1127-2018Class IIDoxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count…Aug 7, 2018
D-0341-2018Class IIPD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30…Jan 25, 2018
D-1118-2017Class IIIPhentermine Capsules, 15 mg, a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle ( NDC…Aug 11, 2017

Recent FDA inspections

4 inspections from May 21, 2009 to Aug 20, 2026.

DateSiteProductClassificationFEI
Aug 20, 2026Oklahoma City, OKDrugsVoluntary Action Indicated (VAI)1641825
Nov 10, 2022Oklahoma City, OKDrugsVoluntary Action Indicated (VAI)1641825
Dec 4, 2015Oklahoma City, OKDrugsVoluntary Action Indicated (VAI)1641825
May 21, 2009Oklahoma City, OKDrugsNo Action Indicated (NAI)1641825
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1641825Oklahoma City, OK4Aug 20, 2026

PD-Rx Pharmaceuticals, Inc. and the FDA: common questions

Has PD-Rx Pharmaceuticals, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "PD-Rx Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has PD-Rx Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "PD-Rx Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect PD-Rx Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Aug 20, 2026 at Oklahoma City, OK and was classified VAI. FDA has 4 inspections of PD-Rx Pharmaceuticals, Inc. on file.

Has PD-Rx Pharmaceuticals, Inc. had an FDA recall?

Yes. PD-Rx Pharmaceuticals, Inc. has 25 FDA recalls on record. The most recent started Dec 4, 2024.

Need more than this page shows? Ask about PD-Rx Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.